Blesl A, Borenich A, Grochenig H, Novacek G, Primas C, Reinisch W
J Clin Med. 2023; 12(14).
PMID: 37510968
PMC: 10382050.
DOI: 10.3390/jcm12144853.
Masuda M, Fukata N, Sano Y, Nishimon S, Aoi M, Tomiyama T
JGH Open. 2022; 6(9):612-620.
PMID: 36091323
PMC: 9446402.
DOI: 10.1002/jgh3.12796.
Huang C, Huang Z, Ding L, Fu Y, Fan J, Mei Q
J Transl Med. 2022; 20(1):354.
PMID: 35962454
PMC: 9373544.
DOI: 10.1186/s12967-022-03569-3.
Bruscoli S, Febo M, Riccardi C, Migliorati G
Front Immunol. 2021; 12:691480.
PMID: 34149734
PMC: 8209469.
DOI: 10.3389/fimmu.2021.691480.
Blackwell J, Selinger C, Raine T, Parkes G, Smith M, Pollok R
Frontline Gastroenterol. 2021; 12(3):207-213.
PMID: 33907617
PMC: 8040510.
DOI: 10.1136/flgastro-2019-101288.
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
Lamb C, Kennedy N, Raine T, Hendy P, Smith P, Limdi J
Gut. 2019; 68(Suppl 3):s1-s106.
PMID: 31562236
PMC: 6872448.
DOI: 10.1136/gutjnl-2019-318484.
Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis.
Zhou H, Qian H
Drug Des Devel Ther. 2018; 12:2601-2609.
PMID: 30174414
PMC: 6110634.
DOI: 10.2147/DDDT.S170676.
Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology.
Dubois-Camacho K, Ottum P, Franco-Munoz D, De la Fuente M, Torres-Riquelme A, Diaz-Jimenez D
World J Gastroenterol. 2017; 23(36):6628-6638.
PMID: 29085208
PMC: 5643284.
DOI: 10.3748/wjg.v23.i36.6628.
Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?.
Vasudevan A, Gibson P, van Langenberg D
World J Gastroenterol. 2017; 23(35):6385-6402.
PMID: 29085188
PMC: 5643264.
DOI: 10.3748/wjg.v23.i35.6385.
Budesonide for the treatment of ulcerative colitis.
Abdalla M, Herfarth H
Expert Opin Pharmacother. 2016; 17(11):1549-59.
PMID: 27157244
PMC: 4989907.
DOI: 10.1080/14656566.2016.1183648.
Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.
Quetglas E, Mujagic Z, Wigge S, Keszthelyi D, Wachten S, Masclee A
World J Gastroenterol. 2015; 21(44):12519-43.
PMID: 26640330
PMC: 4658608.
DOI: 10.3748/wjg.v21.i44.12519.
Oral prolonged release beclomethasone dipropionate and prednisone in the treatment of active ulcerative colitis: results from a double-blind, randomized, parallel group study.
Van Assche G, Manguso F, Zibellini M, Cabriada Nuno J, Goldis A, Tkachenko E
Am J Gastroenterol. 2015; 110(5):708-15.
PMID: 25869389
DOI: 10.1038/ajg.2015.114.
Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease.
Cassan C, Savarino E, Marson P, Tison T, Hatem G, Sturniolo G
World J Gastroenterol. 2014; 20(45):17155-62.
PMID: 25493030
PMC: 4258586.
DOI: 10.3748/wjg.v20.i45.17155.
Doing clinical trials large enough to achieve adequate reductions in uncertainties about treatment effects.
Campbell M
J R Soc Med. 2013; 106(2):68-71.
PMID: 23401637
PMC: 3569016.
DOI: 10.1177/0141076813477570.
Steroids and 5-aminosalicylic acids in moderate ulcerative colitis: addressing the dilemma.
Probert C
Therap Adv Gastroenterol. 2013; 6(1):33-8.
PMID: 23320048
PMC: 3539295.
DOI: 10.1177/1756283X12461395.
Indian Society of Gastroenterology consensus on ulcerative colitis.
Ramakrishna B, Makharia G, Abraham P, Ghoshal U, Jayanthi V, Agarwal B
Indian J Gastroenterol. 2012; 31(6):307-23.
PMID: 23096266
DOI: 10.1007/s12664-012-0259-0.
Diagnosis and management of inflammatory bowel disease.
Buchan D
Can Fam Physician. 2011; 22:47-51.
PMID: 21308011
PMC: 2378197.
Some aspects of medical management of gastrointestinal disease. Part II.
BADLEY B
Can Med Assoc J. 2010; 112(3):331-5.
PMID: 20312630
PMC: 1956331.
New pathophysiological insights and modern treatment of IBD.
Engel M, Neurath M
J Gastroenterol. 2010; 45(6):571-83.
PMID: 20213337
DOI: 10.1007/s00535-010-0219-3.
How important is onset of action in ulcerative colitis therapy?.
Masson S, Nylander D, Mansfield J
Drugs. 2005; 65(15):2069-83.
PMID: 16225364
DOI: 10.2165/00003495-200565150-00001.
